Search Results - "Granger, D. B."

Probing the Wave Function and Dynamics of the Quintet Multiexciton State with Coherent Control in a Singlet Fission Material by Bayliss, S. L., Weiss, L. R., Kraffert, F., Granger, D. B., Anthony, J. E., Behrends, J., Bittl, R.

“…High-spin states play a key role in chemical reactions found in nature. In artificial molecular systems, singlet fission produces a correlated triplet-pair…”
Get full text

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease by Levine, Glenn N., MD, FACC, FAHA, Bates, Eric R., MD, FACC, FAHA, FSCAI, Bittl, John A., MD, FACC, Brindis, Ralph G., MD, MPH, MACC, FAHA, Fihn, Stephan D., MD, MPH, Fleisher, Lee A., MD, FACC, FAHA, Granger, Christopher B., MD, FACC, FAHA, Lange, Richard A., MD, MBA, FACC, Mack, Michael J., MD, FACC, Mauri, Laura, MD, MSc, FACC, FAHA, FSCAI, Mehran, Roxana, MD, FACC, FAHA, FSCAI, Mukherjee, Debabrata, MD, FACC, FAHA, FSCAI, Newby, L. Kristin, MD, MHS, FACC, FAHA, O’Gara, Patrick T., MD, FACC, FAHA, Sabatine, Marc S., MD, MPH, FACC, FAHA, Smith, Peter K., MD, FACC, Smith, Sidney C., MD, FACC, FAHA

Get full text

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction by Levine, Glenn N., MD, FACC, FAHA, O’Gara, Patrick T., MD, FACC, FAHA, Bates, Eric R., MD, FACC, FAHA, FSCAI, Blankenship, James C., MD, FACC, FAHA, FSCAI, Kushner, Frederick G., MD, FACC, FAHA, FSCAI, Bailey, Steven R., MD, FACC, FSCAI, Bittl, John A., MD, FACC, Brindis, Ralph G., MD, MPH, MACC, FSCAI, FAHA, Casey, Donald E., MD, MPH, MBA, FAHA, Cercek, Bojan, MD, FACC, FAHA, Chambers, Charles E., MD, FACC, FSCAI, Chung, Mina K., MD, FACC, FAHA, de Lemos, James A., MD, FACC, Diercks, Deborah B., MD, MSc, Ellis, Stephen G., MD, FACC, Fang, James C., MD, FACC, FAHA, Franklin, Barry A., PhD, FAHA, Granger, Christopher B., MD, FACC, FAHA, Guyton, Robert A., MD, FACC, Hollenberg, Steven M., MD, FACC, Khot, Umesh N., MD, FACC, Krumholz, Harlan M., MD, SM, FACC, FAHA, Lange, Richard A., MD, FACC, FAHA, Linderbaum, Jane A., MS, CNP-BC, Mauri, Laura, MD, MSc, FACC, FSCAI, Mehran, Roxana, MD, FACC, FAHA, FSCAI, Morrow, David A., MD, MPH, FACC, FAHA, Moussa, Issam D., MD, FACC, FAHA, FSCAI, Mukherjee, Debabrata, MD, FACC, FAHA, FSCAI, Newby, L. Kristin, MD, MHS, FACC, FAHA, Ornato, Joseph P., MD, FACC, FAHA, FACP, FACEP, Ou, Narith, PharmD, Radford, Martha J., MD, FACC, FAHA, Tamis-Holland, Jacqueline E., MD, FACC, FSCAI, Ting, Henry H., MD, FACC, FAHA, Tommaso, Carl L., MD, FACC, FAHA, MSCAI, Tracy, Cynthia M., MD, FACC, FAHA, Woo, Y. Joseph, MD, FACC, FAHA, Zhao, David X., MD, FACC

“…Table of Contents Preamble1236 Introduction1237 Methodology and Evidence Review1237 Organization of the GWC1338 Review and Approval1238 Culprit Artery-Only…”
Get full text

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin by Hylek, Elaine M., MD, MPH, Held, Claes, MD, PhD, Alexander, John H., MD, MHS, Lopes, Renato D., MD, PhD, De Caterina, Raffaele, MD, PhD, Wojdyla, Daniel M., MS, Huber, Kurt, MD, Jansky, Petr, MD, Steg, Philippe Gabriel, MD, Hanna, Michael, MD, Thomas, Laine, PhD, Wallentin, Lars, MD, PhD, Granger, Christopher B., MD

“…Objectives This study sought to characterize major bleeding on the basis of the components of the major bleeding definition, to explore major bleeding by…”
Get full text

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial by Mehta, Shamir R, Dr, Tanguay, Jean-Francois, MD, Eikelboom, John W, MD, Jolly, Sanjit S, MD, Joyner, Campbell D, Prof, Granger, Christopher B, MD, Faxon, David P, Prof, Rupprecht, Hans-Jurgen, MD, Budaj, Andrzej, Prof, Avezum, Alvaro, MD, Widimsky, Petr, Prof, Steg, Philippe Gabriel, Prof, Bassand, Jean-Pierre, Prof, Montalescot, Gilles, MD, Macaya, Carlos, MD, Di Pasquale, Giuseppe, MD, Niemela, Kari, MD, Ajani, Andrew E, MD, White, Harvey D, Prof, Chrolavicius, Susan, BA, Gao, Peggy, MSc, Fox, Keith AA, Prof, Yusuf, Salim, Prof

“…Summary Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for percutaneous coronary intervention (PCI). We assessed the…”
Get full text

Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity by Krychtiuk, Konstantin A., Lopes, Renato D., Wojdyla, Daniel M., Goodman, Shaun G., Aronson, Ronald, Windecker, Stephan, Mehran, Roxana, Granger, Christopher B., Alexander, John H., Alexander, Karen P.

“…Patients with atrial fibrillation (AF) after an acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI) with multiple…”
Get full text

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease by Levine, Glenn N., MD, FACC, FAHA, Bates, Eric R., MD, FACC, FAHA, FSCAI, Bittl, John A., MD, FACC, Brindis, Ralph G., MD, MPH, MACC, FAHA, Fihn, Stephan D., MD, MPH, Fleisher, Lee A., MD, FACC, FAHA, Granger, Christopher B., MD, FACC, FAHA, Lange, Richard A., MD, MBA, FACC, Mack, Michael J., MD, FACC, Mauri, Laura, MD, MSc, FACC, FAHA, FSCAI, Mehran, Roxana, MD, FACC, FAHA, FSCAI, Mukherjee, Debabrata, MD, FACC, FAHA, FSCAI, Newby, L. Kristin, MD, MHS, FACC, FAHA, O'Gara, Patrick T., MD, FACC, FAHA, Sabatine, Marc S., MD, MPH, FACC, FAHA, Smith, Peter K., MD, FACC, Smith, Sidney C., MD, FACC, FAHA, Halperin, Jonathan L., MD, FACC, FAHA, Al-Khatib, Sana M., MD, MHS, FACC, FAHA, Birtcher, Kim K., PharmD, MS, AACC, Bozkurt, Biykem, MD, PhD, FACC, FAHA, Cigarroa, Joaquin E., MD, FACC, Curtis, Lesley H., PhD, FAHA, Gentile, Federico, MD, FACC, Gidding, Samuel, MD, FAHA, Hlatky, Mark A., MD, FACC, FAHA, Ikonomidis, John S., MD, PhD, FAHA, Joglar, José A., MD, FACC, FAHA, Pressler, Susan J., PhD, RN, FAHA, Wijeysundera, Duminda N., MD, PhD

Get full text

Novel oral anticoagulants in gastroenterology practice by Desai, Jay, MD, Granger, Christopher B., MD, Weitz, Jeffrey I., MD, Aisenberg, James, MD

Get full text

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation by Flaker, Greg, MD, Lopes, Renato D., MD, PhD, Al-Khatib, Sana M., MD, MHS, Hermosillo, Antonio G., MD, Hohnloser, Stefan H., MD, Tinga, Brian, MS, Zhu, Jun, MD, Mohan, Puneet, MD, PhD, Garcia, David, MD, Bartunek, Jozef, MD, PhD, Vinereanu, Dragos, MD, PhD, Husted, Steen, MD, DMSc, Harjola, Veli Pekka, MD, PhD, Rosenqvist, Marten, MD, Alexander, John H., MD, MHS, Granger, Christopher B., MD

“…Objectives The aim of this study was to determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in subjects…”
Get full text

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial by Easton, J Donald, Dr, Lopes, Renato D, MD, Bahit, M Cecilia, MD, Wojdyla, Daniel M, MS, Granger, Christopher B, MD, Wallentin, Lars, MD, Alings, Marco, MD, Goto, Shinya, MD, Lewis, Basil S, MD, Rosenqvist, Mårten, MD, Hanna, Michael, MD, Mohan, Puneet, MD, Alexander, John H, MD, Diener, Hans-Christoph, MD

“…Summary Background In the ARISTOTLE trial, the rate of stroke or systemic embolism was reduced by apixaban compared with warfarin in patients with atrial…”
Get full text

Medication adherence: A call for action by Bosworth, Hayden B., PhD, Granger, Bradi B., RN, PhD, Mendys, Phil, Pharm D, Brindis, Ralph, MD, Burkholder, Rebecca, JD, Czajkowski, Susan M., PhD, Daniel, Jodi G., JD, MPH, Ekman, Inger, PhD, Ho, Michael, MD, Johnson, Mimi, MPhil, Kimmel, Stephen E., MD, MSCE, Liu, Larry Z., MD, PhD, Musaus, John, Shrank, William H., MD, MSHS, Buono, Elizabeth Whalley, RN, JD, Weiss, Karen, Granger, Christopher B., MD

“…Poor adherence to efficacious cardiovascular-related medications has led to considerable morbidity, mortality, and avoidable health care costs. This article…”
Get full text

Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease by Shah, Svati H., MD, MHS, Sun, Jie-Lena, MS, Stevens, Robert D., PhD, Bain, James R., PhD, Muehlbauer, Michael J., PhD, Pieper, Karen S., MS, Haynes, Carol, BS, Hauser, Elizabeth R., PhD, Kraus, William E., MD, Granger, Christopher B., MD, Newgard, Christopher B., PhD, Califf, Robert M., MD, Newby, L. Kristin, MD, MHS

“…Background Cardiovascular risk models remain incomplete. Small-molecule metabolites may reflect underlying disease and, as such, serve as novel biomarkers of…”
Get full text

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure by Castagno, Davide, MD, Skali, Hicham, MD, MSc, Takeuchi, Madoka, MS, Swedberg, Karl, MD, PhD, Yusuf, Salim, MBBS, DPhil, Granger, Christopher B., MD, Michelson, Eric L., MD, Pfeffer, Marc A., MD, PhD, McMurray, John J.V., MD, Solomon, Scott D., MD

“…Objectives The aim of this study was to explore the relationship between baseline resting heart rate and outcomes in patients with chronic heart failure (HF)…”
Get full text

Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale by Lopes, Renato D., MD, PhD, Alexander, John H., MD, MHS, Al-Khatib, Sana M., MD, MHS, Ansell, Jack, MD, Diaz, Raphael, MD, Easton, J. Donald, MD, Gersh, Bernard J., MB, ChB, DPhil, Granger, Christopher B., MD, Hanna, Michael, MD, Horowitz, John, MD, Hylek, Elaine M., MD, MPH, McMurray, John J.V., MD, Verheugt, Freek W.A., MD, PhD, Wallentin, Lars, MD, PhD

“…Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is…”
Get full text

Characteristics and Outcomes of Adults With Congenital Heart Disease in the Cardiac Intensive Care Unit by Keane, Ryan R., Carnicelli, Anthony P., Loriaux, Daniel B., Kendsersky, Payton, Krasuski, Richard A., Brown, Kelly M., Arps, Kelly, Baird-Zars, Vivian, Dixson, Jeffrey A., Echols, Emily, Granger, Christopher B., Harrison, Robert W., Kontos, Michael, Newby, L. Kristin, Park, Jeong-Gun, Shah, Kevin S., Ternus, Bradley W., Van Diepen, Sean, Katz, Jason N., Morrow, David A.

“…Little is known regarding the characteristics, treatment patterns, and outcomes in patients with adult congenital heart disease (ACHD) admitted to cardiac…”
Get full text

Practical Management of Anticoagulation in Patients With Atrial Fibrillation by Kovacs, Richard J., MD, Flaker, Greg C., MD, Saxonhouse, Sherry J., MD, Doherty, John U., MD, Birtcher, Kim K., PharmD, MS, Cuker, Adam, MD, MS, Davidson, Bruce L., MD, MPH, Giugliano, Robert P., MD, SM, Granger, Christopher B., MD, Jaffer, Amir K., MD, MBA, Mehta, Bella H., PharmD, Nutescu, Edith, PharmD, MS, Williams, Kim A., MD

“…Abstract Anticoagulation for atrial fibrillation has become more complex due to the introduction of new anticoagulant agents, the number and kinds of patients…”
Get full text

High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin by Hijazi, Ziad, MD, PhD, Wallentin, Lars, MD, PhD, Siegbahn, Agneta, MD, PhD, Andersson, Ulrika, MSc, Alexander, John H., MD, MHS, Atar, Dan, MD, Gersh, Bernard J., MB, ChB, DPhil, Hanna, Michael, MD, Harjola, Veli Pekka, MD, PhD, Horowitz, John D., MD, PhD, Husted, Steen, MD, MSc, Hylek, Elaine M., MD, MPH, Lopes, Renato D., MD, PhD, McMurray, John J.V., MD, Granger, Christopher B., MD

“…Objectives The aim of this study was to evaluate the prognostic value of high-sensitivity troponin T (hs-TnT) in addition to clinical risk factors and the CHA2…”
Get full text

A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN) by Van de Werf, Frans, MD, Brueckmann, Martina, MD, Connolly, Stuart J., MD, Friedman, Jeffrey, MD, Granger, Christopher B., MD, Härtter, Sebastian, PhD, Harper, Ruth, MD, Kappetein, Arie Pieter, MD, Lehr, Thorsten, PhD, Mack, Michael J., MD, Noack, Herbert, PhD, Eikelboom, John W., MD

“…Background Vitamin K antagonists are the only oral anticoagulants approved for long-term treatment of patients with a cardiac valve replacement. Objective This…”
Get full text

Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation by Piccini, Jonathan P., MD, MHS, Granger, Christopher B., MD

“…Corresponding Author…”
Get full text

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program by Ariti, Cono A., MSc, Cleland, John G.F., MD, Pocock, Stuart J., PhD, Pfeffer, Marc A., MD, PhD, Swedberg, Karl, MD, PhD, Granger, Christopher B., MD, McMurray, John J.V., MD, Michelson, Eric L., MD, Östergren, Jan, MD, PhD, Yusuf, Salim, MD, DPhil

“…Background Conventional composite outcomes in heart failure (HF) trials, for example, time to cardiovascular death or first HF hospitalization, have recognized…”
Get full text